Traditional Silicon Valley startup models involving venture capital or private equity are missing new markets as health care’s evolution speeds up, says one entrepreneur.
Traditional Silicon Valley startup models involving venture capital or private equity are missing new markets as health care’s evolution speeds up, says one entrepreneur.
Leading pharma companies conspire to keep drug price in the U.S. far higher than a free market would support — and that also stifles innovation, says the author of a new book.
The Joseph H. Lauder Institute
256 South 37th street
2nd Floor
Philadelphia, PA 19104-6330